Table 1.
General characteristics of each group.
| hrHPV+ (n = 320) |
hrHPV−(n = 160) |
χ² | P | |||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Overalla | 203 | 63.4 | 95 | 59.4 | 0.748 | 0.387 |
| UU | 164 | 51.3 | 84 | 52.5 | 0.067 | 0.796 |
| Uuu | 39 | 12.2 | 17 | 10.6 | 0.253 | 0.615 |
| Uup1 | 35 | 10.9 | 17 | 10.6 | 0.011 | 0.917 |
| Uup3 | 58 | 18.1 | 38 | 23.8 | 2.109 | 0.146 |
| Uup6 | 46 | 14.4 | 24 | 15.0 | 0.033 | 0.855 |
| Uup14 | 21 | 6.6 | 24 | 15.0 | 8.938 | 0.003 |
| MH | 77 | 24.1 | 21 | 13.1 | 7.853 | 0.005 |
| MG | 7 | 2.2 | 0 | 0 | 2.193 | 0.139 |
| CT | 16 | 5 | 4 | 2.5 | 1.670 | 0.196 |
| HSV-2 | 3 | 0.9 | 0 | 0 | 0.377 | 0.539 |
aPositive for any STD-causing microorganisms, including multiple infections. hrHPV: high-risk human papillomavirus; UU: Ureaplasma urealyticum; Uuu: Ureaplasma urealyticum biovar; Uup: Ureaplasma parvum serotype; MH: Mycoplasma hominis; MG: Mycoplasma genitalium; CT: Chlamydia trachomatis; HSV-2: herpes simplex virus type 2.